COVID-19

Click here to answer this week's poll.

Evidence suggests a second booster improve protection against severe COVID.

Cancer programs seek to remove barriers to screenings.

Physicians’ group cites CDC data in letter to lawmakers.

Official death toll is almost 6 million, but excess deaths indicate far more may have died from COVID than reported.

State agencies hope to move patients to marketplace

Skipping physicians for convenience not the best way for patients to receive care says AMA.

Rural areas lag well behind their urban counterparts when it comes to COVID-19 vaccinations.

Social media a ‘critical challenge for public health.'

The American Academy of Dermatology meeting, held in Boston, Massachusetts this year, will not be requiring those in attendance to prove their COVID-19 vaccination status.

The American Society for Dermatologic Surgery investigated how the COVID-19 pandemic affected both dermatology practices and patients from staffing reductions to telehealth.

A retrospective cohort study in a research letter published in the Journal of the American Academy of Dermatology examined the risk between atopic dermatitis and COVID-19 risk.

With increased infectivity of Omicron, the Centers for Control and Prevention (CDC) has updated the guidance on the best mask types to use.

Sunscreen advice, recruiting during the “Great Recession”, and tips for the office led the busy agenda at Winter Clinical Dermatology Conference this weekend.

But protection against hospitalization and death remain strong.

An alarming amount of COVID-19 disinformation is prevalent even from physicians.

The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.

A previous analysis found the vaccine was 90.7 percent effective against severe COVID-19.

Lawrence Eichenfield, MD, provides the newest updates in pediatric patient care, with a special update on COVID-19 skin symptoms in children.

Physician well-being has taken a beating throughout the COVID-19 pandemic.

Margins in August still low along with many volume metrics.

The announcement is part of a slate of new vaccine mandates announced Sept. 9.

The organization is also calling on everyone to be vaccinated against the disease.

The National Psoriasis Foundation has released new guidance statements after the Centers for Disease Control and Prevention provided new information on COVID-19 vaccine boosters for immunocompromised patients.

According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.

Some systemic medications may have increased risk for patients during the COVID-19 era, according to a recent Pediatric Dermatology Research Alliance (PeDRA) statement.

COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.

185,000 adults with confirmed cases of COVID-19 were hospitalized in June and July. Of those, 182,000, or 98.3%, had not been vaccinated for the disease.

A jump in new COVID-19 cases dropped margins and volumes.